This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Merck asks US judge to provide benefit of settlement with Cardinal over Zetia

( March 24, 2025, 16:40 GMT | Official Statement) -- MLex Summary: Merck asked a US federal judge to indemnify it from US antitrust claims filed by Cardinal Health and United HealthCare in a case accusing it of entering into an illegal pay-for-delay agreement that kept a generic version of the cholesterol drug Zetia out of the market. Merck said that it litigated and settled claims brought by Cardinal in connection with the same antitrust allegations that UHS makes in its lawsuit. In exchange for a substantial sum of money, Cardinal not only released all its Zetia- and Vytorin-based claims against Merck but also promised to indemnify Merck for all claims Cardinal assigned to UHS. See attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections